ClouDr Group Limited
SEHK:9955 Stok Raporu
ClouDr Group Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6 ClouDr Group yıllık ortalama 35.2% oranında kazançlarını artırırken, Healthcare sektöründe kazançlar growing at 11.2% annual. Gelirler yılda ortalama 31.1% oranında büyüyor .
Anahtar bilgiler Healthcare Sektör Büyümesi 11.3% Gelir büyüme oranı 31.1% Özkaynak getirisi -16.6% Net Marj -7.0% Son Kazanç Güncellemesi 30 Jun 2024
Yakın geçmiş performans güncellemeleri
First half 2024 earnings released: CN¥0.20 loss per share (vs CN¥0.29 loss in 1H 2023) Sep 27
First half 2024 earnings released: CN¥0.20 loss per share (vs CN¥0.29 loss in 1H 2023) Aug 26
ClouDr Group Limited to Report First Half, 2024 Results on Aug 21, 2024 Aug 09 ClouDr Group Limited to Report Fiscal Year 2023 Results on Mar 21, 2024
First half 2023 earnings released: CN¥0.29 loss per share (vs CN¥11.94 loss in 1H 2022) Aug 19
ClouDr Group Limited to Report First Half, 2023 Results on Aug 18, 2023 Aug 09
Tüm güncellemeleri göster
New minor risk - Market cap size Oct 30
New minor risk - Share price stability Sep 30
First half 2024 earnings released: CN¥0.20 loss per share (vs CN¥0.29 loss in 1H 2023) Sep 27
Slammed 29% ClouDr Group Limited (HKG:9955) Screens Well Here But There Might Be A Catch Sep 02
New minor risk - Profitability Aug 28
First half 2024 earnings released: CN¥0.20 loss per share (vs CN¥0.29 loss in 1H 2023) Aug 26
New minor risk - Profitability Aug 22
ClouDr Group Limited to Report First Half, 2024 Results on Aug 21, 2024 Aug 09
Take Care Before Jumping Onto ClouDr Group Limited (HKG:9955) Even Though It's 27% Cheaper Jun 09
ClouDr Group Limited Announces Resignation of Director and Change in Composition of Audit Committee Jun 08
ClouDr Group Limited Announces Application for Market Launch of Vitamin B6 Injection Solution Jun 06
Cautious Investors Not Rewarding ClouDr Group Limited's (HKG:9955) Performance Completely Apr 24
ClouDr Group Limited, Annual General Meeting, Jun 06, 2024 Mar 23
ClouDr Group Limited, Annual General Meeting, Jun 06, 2024 Mar 22 ClouDr Group Limited to Report Fiscal Year 2023 Results on Mar 21, 2024
Cloudr Group Limited Announces Resignation of Liu Mengya as Joint Company Secretary Dec 19
ClouDr Group Limited Announces New Efficacy of Ischelium on Brain Covidative Fund Approval Nov 17
Founder recently bought HK$756k worth of stock Oct 31
Founder recently bought HK$99k worth of stock Sep 02
Consensus EPS estimates upgraded to CN¥0.50 loss Aug 25
First half 2023 earnings released: CN¥0.29 loss per share (vs CN¥11.94 loss in 1H 2022) Aug 19
ClouDr Group Limited to Report First Half, 2023 Results on Aug 18, 2023 Aug 09
Founder recently bought HK$120k worth of stock May 23 Cloudr Group Limited Launches Cloud GPT, ClouD DTx Platform and ClouDTx-CVD
Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind May 04
ClouDr Group Limited (HKG:9955) Soars 67% But It's A Story Of Risk Vs Reward Apr 17
Consensus EPS estimates fall by 17% Mar 29
Full year 2022 earnings: Revenues exceed analyst expectations Mar 24
ClouDr Group Limited (HKG:9955) Shares Could Be 36% Below Their Intrinsic Value Estimate Feb 20
Now 25% undervalued after recent price drop Jan 05
ClouDr Group Limited Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022 Dec 07
High number of new and inexperienced directors Nov 16
An Intrinsic Calculation For ClouDr Group Limited (HKG:9955) Suggests It's 29% Undervalued Oct 07
High number of new and inexperienced directors Aug 01
ClouDr Group nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi SEHK:9955 Gelir, gider ve kazançlar (CNY Millions ) Tarih Gelir Kazançlar G+A Giderleri Ar-Ge Giderleri 30 Jun 24 4,013 -283 1,075 89 31 Mar 24 3,852 -303 1,127 89 31 Dec 23 3,691 -323 1,179 88 30 Sep 23 3,551 -469 1,262 82 30 Jun 23 3,411 -614 1,345 76 31 Mar 23 3,199 -1,152 1,327 95 31 Dec 22 2,988 -1,689 1,308 115 30 Sep 22 2,738 -1,887 1,277 168 30 Jun 22 2,430 -2,844 1,186 207 31 Mar 22 2,093 -3,492 1,123 222 31 Dec 21 1,757 -4,139 1,060 236 30 Sep 21 1,513 -4,701 1,134 227 31 Dec 20 839 -2,867 943 132 31 Dec 19 524 -557 224 24 31 Dec 18 250 -140 105 19
Kaliteli Kazançlar: 9955 şu anda kârlı değil.
Büyüyen Kar Marjı: 9955 şu anda kârlı değil.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: 9955 kârlı değildir, ancak son 5 yılda zararlarını yılda 35.2% oranında azaltmıştır.
Büyüme Hızlandırma: 9955 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil
Kazançlar vs. Sektör: 9955 kârlı olmadığından, geçmiş yıl kazanç büyümesinin Healthcare sektörüyle ( -16.9% ) karşılaştırılması zorlaşıyor.
Özkaynak Getirisi
Yüksek ROE: 9955 hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi 'ne ( -16.62% ) sahiptir.
Kullanılan Sermaye Getirisi
Geçmişte güçlü performans gösteren şirketleri keşfedin Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
